# Cohu Inc: financial statements, quarterly

COHU · Nasdaq · CIK 21535 · [Technology](/sectors/technology.md) · fiscal year ends Dec 26

Pages: [Overview](/companies/cohu.md) · [Financials](/companies/cohu/financials.md) · [Filings](/companies/cohu/filings.md) · [Insiders](/companies/cohu/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cohu/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) | Q3 FY2026 (2026-09-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [137 d](/filings/0001437749-26-004339.md) | [108](/filings/0001437749-25-014183.md) | [105](/filings/0001437749-25-024281.md) | [95.3](/filings/0001437749-25-032269.md) | [94.1 d](/filings/0001437749-26-004339.md) | [96.8](/filings/0001437749-26-014308.md) | [108](/filings/0001437749-26-025144.md) | [126](/filings/0001437749-26-033843.md) | [122 d](/filings/0001437749-26-004339.md) | [125](/filings/0001437749-26-014308.md) | [149](/filings/0001437749-26-025144.md) | [173](/filings/0001437749-26-033843.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [22.1 d](/filings/0001437749-26-004339.md) | [22.3](/filings/0001437749-25-014183.md) | [21.3](/filings/0001437749-25-024281.md) | [20.3](/filings/0001437749-25-032269.md) | [20.8 d](/filings/0001437749-26-004339.md) | [23.2](/filings/0001437749-26-014308.md) | [23.2](/filings/0001437749-26-025144.md) | [22.5](/filings/0001437749-26-033843.md) | [23.4 d](/filings/0001437749-26-004339.md) | [26.4](/filings/0001437749-26-014308.md) | [24.9](/filings/0001437749-26-025144.md) | [25.6](/filings/0001437749-26-033843.md) |
| Selling, general and administrative | $m | [32.8 d](/filings/0001437749-26-004339.md) | [35.1](/filings/0001437749-25-014183.md) | [32.1](/filings/0001437749-25-024281.md) | [30.3](/filings/0001437749-25-032269.md) | [30.5 d](/filings/0001437749-26-004339.md) | [30.0](/filings/0001437749-26-014308.md) | [29.9](/filings/0001437749-26-025144.md) | [31.8](/filings/0001437749-26-033843.md) | [31.9 d](/filings/0001437749-26-004339.md) | [34.6](/filings/0001437749-26-014308.md) | [34.4](/filings/0001437749-26-025144.md) | [32.7](/filings/0001437749-26-033843.md) |
| Operating income | $m | [0.3 d](/filings/0001437749-26-004339.md) | [(18.0)](/filings/0001437749-25-014183.md) | [(16.3)](/filings/0001437749-25-024281.md) | [(15.8)](/filings/0001437749-25-032269.md) | [(21.6) d](/filings/0001437749-26-004339.md) | [(27.3)](/filings/0001437749-26-014308.md) | [(17.2)](/filings/0001437749-26-025144.md) | [(9.7)](/filings/0001437749-26-033843.md) | [(15.5) d](/filings/0001437749-26-004339.md) | [(11.2)](/filings/0001437749-26-014308.md) | [0.3](/filings/0001437749-26-025144.md) | [12.8](/filings/0001437749-26-033843.md) |
| Interest expense | $m | [0.8 d](/filings/0001437749-26-004339.md) | [0.3](/filings/0001437749-25-014183.md) | [0.1](/filings/0001437749-25-024281.md) | [0.1](/filings/0001437749-25-032269.md) | [0.1 d](/filings/0001437749-26-004339.md) | [0.2](/filings/0001437749-26-014308.md) | [0.1](/filings/0001437749-26-025144.md) | [0.1](/filings/0001437749-26-033843.md) | [1.6 d](/filings/0001437749-26-004339.md) | [1.6](/filings/0001437749-26-014308.md) | [1.6](/filings/0001437749-26-025144.md) | [1.8](/filings/0001437749-26-033843.md) |
| Income tax | $m | [1.5 d](/filings/0001437749-26-004339.md) | [(1.7)](/filings/0001437749-25-014183.md) | [1.3](/filings/0001437749-25-024281.md) | [3.2](/filings/0001437749-25-032269.md) | [2.1 d](/filings/0001437749-26-004339.md) | [4.8](/filings/0001437749-26-014308.md) | [2.0](/filings/0001437749-26-025144.md) | [(3.7)](/filings/0001437749-26-033843.md) | [8.7 d](/filings/0001437749-26-004339.md) | [3.1](/filings/0001437749-26-014308.md) | [2.1](/filings/0001437749-26-025144.md) | [2.2](/filings/0001437749-26-033843.md) |
| Net income | $m | [(2.0) d](/filings/0001437749-26-004339.md) | [(14.6)](/filings/0001437749-25-014183.md) | [(15.8)](/filings/0001437749-25-024281.md) | [(18.1)](/filings/0001437749-25-032269.md) | [(21.4) d](/filings/0001437749-26-004339.md) | [(30.8)](/filings/0001437749-26-014308.md) | [(16.9)](/filings/0001437749-26-025144.md) | [(4.1)](/filings/0001437749-26-033843.md) | [(22.5) d](/filings/0001437749-26-004339.md) | [(12.1)](/filings/0001437749-26-014308.md) | [(0.2)](/filings/0001437749-26-025144.md) | [12.1](/filings/0001437749-26-033843.md) |
| Diluted EPS | $ per share | not reported | [(0.31)](/filings/0001437749-25-014183.md) | [(0.34)](/filings/0001437749-25-024281.md) | [(0.39)](/filings/0001437749-25-032269.md) | not reported | [(0.66)](/filings/0001437749-26-014308.md) | [(0.36)](/filings/0001437749-26-025144.md) | [(0.09)](/filings/0001437749-26-033843.md) | not reported | [(0.26)](/filings/0001437749-26-014308.md) | [0.00](/filings/0001437749-26-025144.md) | [0.22](/filings/0001437749-26-033843.md) |
| Basic EPS | $ per share | not reported | [(0.31)](/filings/0001437749-25-014183.md) | [(0.34)](/filings/0001437749-25-024281.md) | [(0.39)](/filings/0001437749-25-032269.md) | not reported | [(0.66)](/filings/0001437749-26-014308.md) | [(0.36)](/filings/0001437749-26-025144.md) | [(0.09)](/filings/0001437749-26-033843.md) | not reported | [(0.26)](/filings/0001437749-26-014308.md) | [0.00](/filings/0001437749-26-025144.md) | [0.26](/filings/0001437749-26-033843.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) | Q3 FY2026 (2026-09-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [246](/filings/0001437749-25-004612.md) | [191](/filings/0001437749-24-014436.md) | [203](/filings/0001437749-24-024178.md) | [189](/filings/0001437749-24-032864.md) | [206](/filings/0001437749-26-004339.md) | [152](/filings/0001437749-25-014183.md) | [164](/filings/0001437749-25-024281.md) | [150](/filings/0001437749-25-032269.md) | [227](/filings/0001437749-26-033843.md) | [211](/filings/0001437749-26-014308.md) | [220](/filings/0001437749-26-025144.md) | [272](/filings/0001437749-26-033843.md) |
| Current assets | $m | [639](/filings/0001437749-25-004612.md) | [573](/filings/0001437749-24-014436.md) | [546](/filings/0001437749-24-024178.md) | [542](/filings/0001437749-24-032864.md) | [534](/filings/0001437749-26-004339.md) | [479](/filings/0001437749-25-014183.md) | [491](/filings/0001437749-25-024281.md) | [514](/filings/0001437749-25-032269.md) | [750](/filings/0001437749-26-033843.md) | [754](/filings/0001437749-26-014308.md) | [789](/filings/0001437749-26-025144.md) | [836](/filings/0001437749-26-033843.md) |
| Total assets | $m | [1,150](/filings/0001437749-25-004612.md) | [1,074](/filings/0001437749-24-014436.md) | [1,039](/filings/0001437749-24-024178.md) | [1,032](/filings/0001437749-24-032864.md) | [999](/filings/0001437749-26-004339.md) | [976](/filings/0001437749-25-014183.md) | [1,010](/filings/0001437749-25-024281.md) | [1,021](/filings/0001437749-25-032269.md) | [1,243](/filings/0001437749-26-033843.md) | [1,235](/filings/0001437749-26-014308.md) | [1,258](/filings/0001437749-26-025144.md) | [1,298](/filings/0001437749-26-033843.md) |
| Current liabilities | $m | [103](/filings/0001437749-25-004612.md) | [91.1](/filings/0001437749-24-014436.md) | [78.6](/filings/0001437749-24-024178.md) | [85.0](/filings/0001437749-24-032864.md) | [85.2](/filings/0001437749-26-004339.md) | [92.0](/filings/0001437749-25-014183.md) | [101](/filings/0001437749-25-024281.md) | [117](/filings/0001437749-25-032269.md) | [109](/filings/0001437749-26-033843.md) | [117](/filings/0001437749-26-014308.md) | [137](/filings/0001437749-26-025144.md) | [162](/filings/0001437749-26-033843.md) |
| Long-term debt | $m | [34.3](/filings/0001437749-25-004612.md) | [8.0](/filings/0001437749-24-014436.md) | [7.6](/filings/0001437749-24-024178.md) | [7.9](/filings/0001437749-24-032864.md) | [7.1](/filings/0001437749-26-004339.md) | [7.1](/filings/0001437749-25-014183.md) | [7.3](/filings/0001437749-25-024281.md) | [6.9](/filings/0001437749-25-032269.md) | [285](/filings/0001437749-26-033843.md) | [285](/filings/0001437749-26-014308.md) | [285](/filings/0001437749-26-025144.md) | [285](/filings/0001437749-26-033843.md) |
| Current portion of debt | $m | [6.3](/filings/0001437749-25-004612.md) | [2.8](/filings/0001437749-24-014436.md) | [2.4](/filings/0001437749-24-024178.md) | [2.6](/filings/0001437749-24-032864.md) | [1.7](/filings/0001437749-26-004339.md) | [10.7](/filings/0001437749-25-014183.md) | [11.1](/filings/0001437749-25-024281.md) | [11.0](/filings/0001437749-25-032269.md) | [11.1](/filings/0001437749-26-033843.md) | [11.0](/filings/0001437749-26-014308.md) | [11.2](/filings/0001437749-26-025144.md) | [16.8](/filings/0001437749-26-033843.md) |
| Shareholders' equity | $m | [950](/filings/0001437749-26-004339.md) | [915](/filings/0001437749-25-024281.md) | [896](/filings/0001437749-25-032269.md) | [885](/filings/0001437749-25-032269.md) | [857](/filings/0001437749-26-033843.md) | [828](/filings/0001437749-26-025144.md) | [831](/filings/0001437749-26-033843.md) | [831](/filings/0001437749-26-033843.md) | [786](/filings/0001437749-26-033843.md) | [769](/filings/0001437749-26-025144.md) | [775](/filings/0001437749-26-033843.md) | [791](/filings/0001437749-26-033843.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q4 FY2024 (2024-12-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q4 FY2025 (2025-12-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) | Q3 FY2026 (2026-09-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2.7 d](/filings/0001437749-26-004339.md) | [(14.0)](/filings/0001437749-25-014183.md) | [1.1 d](/filings/0001437749-25-024281.md) | [17.4 d](/filings/0001437749-25-032269.md) | [(1.7) d](/filings/0001437749-26-004339.md) | [(10.2)](/filings/0001437749-26-014308.md) | [16.0 d](/filings/0001437749-26-025144.md) | [(14.0) d](/filings/0001437749-26-033843.md) | [39.8 d](/filings/0001437749-26-004339.md) | [10.3](/filings/0001437749-26-014308.md) | [10.4 d](/filings/0001437749-26-025144.md) | [5.6 d](/filings/0001437749-26-033843.md) |
| Capital expenditure | $m | [3.9 d](/filings/0001437749-26-004339.md) | [3.3](/filings/0001437749-25-014183.md) | [2.0 d](/filings/0001437749-25-024281.md) | [2.3 d](/filings/0001437749-25-032269.md) | [3.0 d](/filings/0001437749-26-004339.md) | [11.0](/filings/0001437749-26-014308.md) | [2.7 d](/filings/0001437749-26-025144.md) | [4.0 d](/filings/0001437749-26-033843.md) | [3.4 d](/filings/0001437749-26-004339.md) | [2.0](/filings/0001437749-26-014308.md) | [2.3 d](/filings/0001437749-26-025144.md) | [2.6 d](/filings/0001437749-26-033843.md) |
| Dividends paid | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Share repurchases | $m | [12.8 d](/filings/0001437749-26-004339.md) | [10.7](/filings/0001437749-25-014183.md) | [8.2 d](/filings/0001437749-25-024281.md) | [8.1 d](/filings/0001437749-25-032269.md) | [0.0 d](/filings/0001437749-26-004339.md) | [8.4](/filings/0001437749-26-014308.md) | [0.1 d](/filings/0001437749-26-025144.md) | [(0.0) d](/filings/0001437749-26-033843.md) | [0.0 d](/filings/0001437749-26-004339.md) | [0.0](/filings/0001437749-26-014308.md) | [0.0 d](/filings/0001437749-26-025144.md) | [0.0 d](/filings/0001437749-26-033843.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: not reported
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-04-01) | Q2 FY2023 (2023-07-01) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-30) | Q2 FY2024 (2024-06-29) | Q3 FY2024 (2024-09-28) | Q1 FY2025 (2025-03-29) | Q2 FY2025 (2025-06-28) | Q3 FY2025 (2025-09-27) | Q1 FY2026 (2026-03-28) | Q2 FY2026 (2026-06-27) | Q3 FY2026 (2026-09-26) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [48.2](/filings/0001437749-24-014436.md) | [48.0](/filings/0001437749-24-024178.md) | [48.1](/filings/0001437749-24-032864.md) | [47.1](/filings/0001437749-25-014183.md) | [47.0](/filings/0001437749-25-024281.md) | [46.8](/filings/0001437749-25-032269.md) | [46.6](/filings/0001437749-26-014308.md) | [46.7](/filings/0001437749-26-025144.md) | [46.7](/filings/0001437749-26-033843.md) | [47.0](/filings/0001437749-26-014308.md) | [47.3](/filings/0001437749-26-025144.md) | [54.4](/filings/0001437749-26-033843.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 47,346,050 at 2026-10-20, from the cover of the [10-Q filed 2026-10-29](/filings/0001437749-26-033843.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 06:27 ET. No prices; not investment advice.